Human papillomavirus (HPV) types 16/18, included in HPV vaccines, contribute to the
majority of cervical cancer, and a substantial proportion of cervical intraepithelial neoplasia (CIN) …

Importance Determining vaccine dose-level protection is essential to minimize program
costs and increase mass vaccination program feasibility. Currently, a 3-dose vaccination …

Background More than 10 years have elapsed since human papillomavirus (HPV) vaccination
was implemented. We did a systematic review and meta-analysis of the population-level …

Background. More than 90% of genital warts (GW) cases are caused by human papillomavirus
(HPV) types 6 and 11. The introduction of HPV vaccines necessitates the estimation of …

Background WHO aims to eliminate cervical cancer. Whether women with mental illness
constitute a group at high-risk and require targeted prevention initiatives remains unknown. We …

Background Incidence of condyloma, or genital warts (GW), is the earliest possible disease
outcome to measure when assessing the effectiveness of human papillomavirus (HPV) …

Background Concerns have been raised that HPV-vaccination might affect women’s cervical
screening behavior. We therefore investigated the association between opportunistic HPV-…

Background Based on immunogenicity studies, a 2 dose HPV vaccination-schedule was
recently recommended for girls younger than 15 years. We aimed to investigate the …

Background Between 2007 and 2011, opportunistic HPV-vaccination was available in
Sweden and partially subsidized to girls aged 13–17, reaching a ∼30% overall coverage. …

Importance Individuals with a mental disorder experience substantial health disparity and
are less likely to participate in cervical screening and human papillomavirus vaccination. …